Stifel – so far - is on the hook for more than $166 million in damages, legal fees and settlements in investor complaints ...

Some investors recently have seen million dollar plus decisions by FINRA arbitration panels involving complex products ...

Panelists on a FINRA arbitration board cited Randy Anderson's claims of age discrimination when questioning UBS's reasons for ...

Stifel Financial recruited an advisor team that oversaw $2.1 billion in client assets at Oppenheimer & Co., making another big hire for Stifel this year.

"I've always really enjoyed what I do," said Henry, who began doing legal work involving municipal securities in 1981.

FINRA published today the 2025 FINRA Industry Snapshot, the annual statistical report on registered representatives, brokerage firms and market activity that ...

FINRA published today the 2025 FINRA Industry Snapshot, the annual statistical report on registered representatives, brokerage firms and market activity that FINRA oversees.

Investing.com - Stifel raised its price target on Rhythm Pharmaceuticals (NASDAQ: RYTM) to $123.00 from $94.00 while maintaining a Buy rating on the stock. The company, currently valued at $5.5 ...

Stifel expressed bullishness on both the product launch and Kalvista’s stock potential, suggesting "meaningful upside given modest buyside expectations" for the newly approved HAE treatment.

ST. LOUIS, June 11, 2025 (GLOBE NEWSWIRE) -- Stifel Financial Corp. (NYSE: SF) today announced that Victor Nesi, Co-President and Head of the Institutional Group, will retire from his day-to-day ...